Expedited ReviewHeart Valve DiseaseUpdated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation: The Valve Academic Research Consortium-2 Consensus Document†
Cited by (0)
All rights reserved. © The Author 2012. For permissions please email: [email protected]. Grants have been provided to the ARC Board including representatives of Cardialysis, the Cardiovascular Research Foundation, Duke Clinical Research Institute, and Harvard Clinical Research Institute to cover the costs of travel, meeting rooms, and lodging for academic attendees at the Washington and Rotterdam meetings by Abbott Vascular, Boston Scientific, Direct Flow Medical, Edwards Lifesciences, Heart Leaflet Technologies, Medtronic Corporation, and St. Jude Medical. VARC Participants will provide Conflict of Interest Disclosures individually prior to publication. The VARC meetings involved members of the Interventional Cardiology Devices Branch, of the Office of Device Evaluation, Center for Devices and Radiological Health, USFDA. The opinions or assertions herein are the private views of the authors and are not to be construed as reflecting the views of the FDA.
- †
The Valve Academic Research Consortium (VARC) consists of representatives from several independent Academic Research Organization, several Surgery and Cardiology Societies, members of the U.S. Food and Drug Administration (FDA), and several independents experts. However, it is not a society document. Neither the societies nor the FDA have been asked to endorse the document.